Literature DB >> 16107228

Epidemiology of sepsis: recent advances.

Pajman Danai1, Greg S Martin.   

Abstract

Sepsis, as defined by an expert consensus definition, is the development of the systemic inflammatory response syndrome in the presence of infection. Using this clinically applicable definition, several studies have evaluated the epidemiology of sepsis over the past decade. The current incidence of sepsis is at least 240 patients per 100,000 people in the United States population, whereas for severe sepsis it is between 51 and 95 patients per 100,000 people. The incidence rate for sepsis has been increasing over the past two decades, driving an increase in the number of deaths despite a decline in case-fatality rates. Sepsis is the tenth leading cause of death in the United States and accounts for more than 17 billion dollars in direct healthcare expenditures.

Entities:  

Year:  2005        PMID: 16107228     DOI: 10.1007/s11908-005-0005-1

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  22 in total

1.  Increase in National Hospital Discharge Survey rates for septicemia--United States, 1979-1987.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1990-01-19       Impact factor: 17.586

2.  Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

Authors:  B L Warren; A Eid; P Singer; S S Pillay; P Carl; I Novak; P Chalupa; A Atherstone; I Pénzes; A Kübler; S Knaub; H O Keinecke; H Heinrichs; F Schindel; M Juers; R C Bone; S M Opal
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

3.  Epidemiology of sepsis in Victoria, Australia.

Authors:  Vijaya Sundararajan; Christopher M Macisaac; Jeffrey J Presneill; John F Cade; Kumar Visvanathan
Journal:  Crit Care Med       Date:  2005-01       Impact factor: 7.598

4.  The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group.

Authors:  G R Bernard; A P Wheeler; J A Russell; R Schein; W R Summer; K P Steinberg; W J Fulkerson; P E Wright; B W Christman; W D Dupont; S B Higgins; B B Swindell
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

5.  Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.

Authors:  Edward Abraham; Konrad Reinhart; Steven Opal; Ignace Demeyer; Christopher Doig; Angel López Rodriguez; Richard Beale; Petr Svoboda; Pierre Francois Laterre; Stuart Simon; Bruce Light; Herbert Spapen; Judy Stone; Allan Seibert; Claus Peckelsen; Cathy De Deyne; Russell Postier; Ville Pettilä; Charles L Sprung; Antonio Artigas; Sandra R Percell; Vincent Shu; Christian Zwingelstein; Jeffrey Tobias; Lona Poole; James C Stolzenbach; Abla A Creasey
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

Review 6.  Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome)

Authors:  R C Bone
Journal:  JAMA       Date:  1992 Dec 23-30       Impact factor: 56.272

7.  EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units.

Authors:  C Brun-Buisson; P Meshaka; P Pinton; B Vallet
Journal:  Intensive Care Med       Date:  2004-03-02       Impact factor: 17.440

8.  Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units.

Authors:  Simon Finfer; Rinaldo Bellomo; Jeffrey Lipman; Craig French; Geoffrey Dobb; John Myburgh
Journal:  Intensive Care Med       Date:  2004-02-12       Impact factor: 17.440

9.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

10.  Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis.

Authors:  C Brun-Buisson; F Doyon; J Carlet; P Dellamonica; F Gouin; A Lepoutre; J C Mercier; G Offenstadt; B Régnier
Journal:  JAMA       Date:  1995-09-27       Impact factor: 56.272

View more
  28 in total

Review 1.  Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes.

Authors:  Greg S Martin
Journal:  Expert Rev Anti Infect Ther       Date:  2012-06       Impact factor: 5.091

2.  Bugs, genes, and the intensive care unit.

Authors:  Kerina Jane Denny; Jeffrey Lipman
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

3.  S-Nitrosoglutathione ameliorates acute renal dysfunction in a rat model of lipopolysaccharide-induced sepsis.

Authors:  Devadoss J Samuvel; Anandakumar Shunmugavel; Avtar K Singh; Inderjit Singh; Mushfiquddin Khan
Journal:  J Pharm Pharmacol       Date:  2016-08-03       Impact factor: 3.765

4.  Early physical rehabilitation in intensive care patients with sepsis syndromes: a pilot randomised controlled trial.

Authors:  Geetha Kayambu; Robert Boots; Jennifer Paratz
Journal:  Intensive Care Med       Date:  2015-04-08       Impact factor: 17.440

5.  A myeloid hypoxia-inducible factor 1α-Krüppel-like factor 2 pathway regulates gram-positive endotoxin-mediated sepsis.

Authors:  Ganapati H Mahabeleshwar; Muhammad Awais Qureshi; Yoichi Takami; Nikunj Sharma; Jerry B Lingrel; Mukesh K Jain
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

6.  Early Versus Delayed Source Control in Open Abdomen Management for Severe Intra-abdominal Infections: A Retrospective Analysis on 111 Cases.

Authors:  Stefano Rausei; Vincenzo Pappalardo; Laura Ruspi; Antonio Colella; Simone Giudici; Vincenzo Ardita; Francesco Frattini; Francesca Rovera; Luigi Boni; Gianlorenzo Dionigi
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352

7.  Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis: A Randomized, Placebo-Controlled Trial.

Authors:  Sadeq A Quraishi; Gennaro De Pascale; Joseph S Needleman; Harumasa Nakazawa; Masao Kaneki; Ednan K Bajwa; Carlos A Camargo; Ishir Bhan
Journal:  Crit Care Med       Date:  2015-09       Impact factor: 7.598

8.  Acute acalculous cholecystitis-like phenotype in scavenger receptor A knock-out mice.

Authors:  Robert Drummond; Donghuan Song; Dennis Hawisher; Paul L Wolf; Daniel E Vazquez; Diego F Nino; Raul Coimbra; David M Cauvi; Antonio De Maio
Journal:  J Surg Res       Date:  2011-01-22       Impact factor: 2.192

9.  Sphingosine kinase-1 is required for toll mediated beta-defensin 2 induction in human oral keratinocytes.

Authors:  Manjunatha R Benakanakere; Jiawei Zhao; Johnah C Galicia; Michael Martin; Denis F Kinane
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

10.  Sepsis without borders.

Authors:  Rui P Moreno; Greg S Martin
Journal:  Intensive Care Med       Date:  2013-11-29       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.